IDEXX Labs Earnings, Revenue Miss in Q2
2022.08.02 14:22
IDEXX Labs Earnings, Revenue Miss in Q2
Investing.com – IDEXX Labs (NASDAQ:IDXX) reported on Tuesday second quarter earnings that missed analysts’ forecasts and revenue that fell short of expectations.
IDEXX Labs announced earnings per share of $1.58 on revenue of $860.55M. Analysts polled by Investing.com anticipated EPS of $1.65 on revenue of $864.61M.
IDEXX Labs shares are down 39.54% from the beginning of the year, still down 43.65% from its 52 week high of $706.51 set on August 4, 2021. They are under-performing the Nasdaq which is down 20.94% from the start of the year.
IDEXX Labs follows other major Healthcare sector earnings this month
IDEXX Labs’s report follows an earnings beat by UnitedHealth on July 15, who reported EPS of $5.57 on revenue of $80.33B, compared to forecasts EPS of $5.21 on revenue of $79.68B.
J&J had beat expectations on July 19 with second quarter EPS of $2.59 on revenue of $24.02B, compared to forecast for EPS of $2.54 on revenue of $23.77B.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com’s earnings calendar
